| Nome |
# |
|
Clinical implications of the hyperdynamic syndrome in cirrhosis., file e3ad8916-d293-da0e-e053-3705fe0a2b96
|
1.994
|
|
Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea, file e3ad8916-5915-da0e-e053-3705fe0a2b96
|
808
|
|
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference, file e3ad8919-4883-da0e-e053-3705fe0a2b96
|
550
|
|
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients, file e3ad8916-5b30-da0e-e053-3705fe0a2b96
|
535
|
|
The
relationship between transient elastography and histological collagen
proportionate area for assessing fibrosis in chronic viral hepatitis, file e3ad8916-5655-da0e-e053-3705fe0a2b96
|
513
|
|
Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease, file e3ad891a-2ca1-da0e-e053-3705fe0a2b96
|
501
|
|
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy, file e3ad8916-5aa8-da0e-e053-3705fe0a2b96
|
447
|
|
Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal
varices in patients with compensated hepatitis C virus cirrhosis, file e3ad8916-5aff-da0e-e053-3705fe0a2b96
|
405
|
|
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B, file e3ad8916-5312-da0e-e053-3705fe0a2b96
|
387
|
|
Clinical course and outcomes of drug-induced liver injury: Nimesulide as the first implicated medication., file e3ad891a-5888-da0e-e053-3705fe0a2b96
|
376
|
|
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response, file e3ad891b-ba87-da0e-e053-3705fe0a2b96
|
370
|
|
Hepatocellular carcinoma and direct-acting antivirals: A never ending story?, file e3ad891b-be35-da0e-e053-3705fe0a2b96
|
335
|
|
AISF position paper on liver disease and pregnancy., file e3ad8919-9b5d-da0e-e053-3705fe0a2b96
|
308
|
|
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C, file e3ad8916-efbf-da0e-e053-3705fe0a2b96
|
305
|
|
Hepassocin as a treatment for fulminant hepatic failure: will it
translate from rats to human?, file e3ad8916-52fd-da0e-e053-3705fe0a2b96
|
298
|
|
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?, file e3ad8916-a3dd-da0e-e053-3705fe0a2b96
|
291
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad891c-add2-da0e-e053-3705fe0a2b96
|
288
|
|
Meccanismi immunologici e molecolari del danno epatico da farmaci, file e3ad891f-edab-da0e-e053-3705fe0a2b96
|
277
|
|
Pegylated-interferon-α(2a) in clinical
practice: how to manage patients suffering from side effects, file e3ad8916-54fb-da0e-e053-3705fe0a2b96
|
275
|
|
A focus on epidemiology of drug-induced liver injury: analysis of a prospective cohort, file e3ad891b-b760-da0e-e053-3705fe0a2b96
|
269
|
|
Digital image analysis of collagen assessment of progression of fibrosis in
recurrent HCV after liver transplantation, file e3ad8916-5315-da0e-e053-3705fe0a2b96
|
265
|
|
Fibrosis in chronic viral hepatitis, file e3ad8916-5b32-da0e-e053-3705fe0a2b96
|
264
|
|
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices., file e3ad8916-596a-da0e-e053-3705fe0a2b96
|
244
|
|
Immunological alterations in hepatitis C virus infection, file e3ad8916-a457-da0e-e053-3705fe0a2b96
|
237
|
|
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program, file e3ad891a-1180-da0e-e053-3705fe0a2b96
|
231
|
|
Liver stiffness measurement by transient elastography predicts early recovery from acute hepatitis, file e3ad8916-5d29-da0e-e053-3705fe0a2b96
|
225
|
|
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin, file e3ad8916-a454-da0e-e053-3705fe0a2b96
|
225
|
|
Histological subclassification of cirrhosis, file e3ad8916-5aad-da0e-e053-3705fe0a2b96
|
220
|
|
IL28B polymorphisms influence stage of fibrosis and
spontaneous or interferon-induced viral clearance in thalassemia patients with
hepatitis C virus infection., file e3ad8916-5b36-da0e-e053-3705fe0a2b96
|
215
|
|
Critically ill patients with cirrhosis and low serum sodium., file e3ad8916-5aa5-da0e-e053-3705fe0a2b96
|
203
|
|
Digital image analysis of liver collagen predicts clinical
outcome of recurrent hepatitis C virus 1 year after liver transplantation., file e3ad8916-5300-da0e-e053-3705fe0a2b96
|
194
|
|
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program., file e3ad891e-b513-da0e-e053-3705fe0a2b96
|
191
|
|
Comparison of cystatin C and creatinine-based glomerular filtration
rate formulas with 51Cr-EDTA clearance in patients with cirrhosis, file e3ad8916-54f8-da0e-e053-3705fe0a2b96
|
187
|
|
Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis., file e3ad891c-746d-da0e-e053-3705fe0a2b96
|
184
|
|
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, file e3ad891c-8ce3-da0e-e053-3705fe0a2b96
|
179
|
|
Comparison of Histochemical Stainings in Evaluation of Liver Fibrosis and Correlation with Transient Elastography in Chronic Hepatitis, file e3ad8918-8032-da0e-e053-3705fe0a2b96
|
177
|
|
Quantification of fibrosis by collagen proportionate area predicts hepatic decompensation in hepatitis C cirrhosis, file e3ad891c-d3b2-da0e-e053-3705fe0a2b96
|
176
|
|
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis, file e3ad8918-821d-da0e-e053-3705fe0a2b96
|
149
|
|
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis., file e3ad8916-a282-da0e-e053-3705fe0a2b96
|
141
|
|
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV, file e3ad891b-be40-da0e-e053-3705fe0a2b96
|
129
|
|
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance, file e3ad8916-5e58-da0e-e053-3705fe0a2b96
|
126
|
|
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population., file e3ad891c-c0d4-da0e-e053-3705fe0a2b96
|
119
|
|
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)., file e3ad891c-75d0-da0e-e053-3705fe0a2b96
|
103
|
|
Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye., file e3ad891c-d3ae-da0e-e053-3705fe0a2b96
|
83
|
|
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens, file e3ad891b-bcdf-da0e-e053-3705fe0a2b96
|
72
|
|
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network, file e3ad891b-977a-da0e-e053-3705fe0a2b96
|
64
|
|
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy, file e3ad8916-5aaa-da0e-e053-3705fe0a2b96
|
51
|
|
Why do I treat my patients with mild hepatitis C?, file e3ad891c-d3a5-da0e-e053-3705fe0a2b96
|
49
|
|
Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation, file e3ad8916-557e-da0e-e053-3705fe0a2b96
|
41
|
|
COMPUTER ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN: RELATIONSHIP TO ESOPHAGEAL VARICES, LIVER DECOMPENSATION AND SVR IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS, file e3ad8916-c1c0-da0e-e053-3705fe0a2b96
|
38
|
|
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials, file e3ad8927-f1d5-da0e-e053-3705fe0a2b96
|
38
|
|
Heart rate variability is associated with disease severity and portal hypertension in cirrhosis, file dfacd35c-0c9d-4cd9-b9ae-9fc78730648f
|
35
|
|
Digital image analysis of collagen assessment of progression of fibrosis in
recurrent HCV after liver transplantation, file e3ad8916-5b3e-da0e-e053-3705fe0a2b96
|
29
|
|
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort, file e3ad8927-c830-da0e-e053-3705fe0a2b96
|
21
|
|
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort, file e3ad8926-b3ad-da0e-e053-3705fe0a2b96
|
18
|
|
Corrigendum to 'Baveno VII - Renewing consensus in portal hypertension' [J Hepatol (2022) 959-974], file 3873526c-efc8-4e35-bba9-de87f386de52
|
15
|
|
MECCANISMI IMMUNOLOGICI E MOLECOLARI DEL DANNO EPATICO DA FARMACI, file e3ad8916-9f7f-da0e-e053-3705fe0a2b96
|
15
|
|
Digital image analysis of collagen assessment of progression of fibrosis in
recurrent HCV after liver transplantation, file e3ad8916-5316-da0e-e053-3705fe0a2b96
|
14
|
|
Baveno VII – Renewing consensus in portal hypertension, file e3ad8927-d49d-da0e-e053-3705fe0a2b96
|
10
|
|
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease, file 13eb37ee-72fe-4bfe-8fd8-f24dee5a8a14
|
9
|
|
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid, file c5332b5d-07c4-4fb9-8d95-5fecaae3c1c3
|
9
|
|
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease, file e3ad8927-204e-da0e-e053-3705fe0a2b96
|
9
|
|
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs., file e3ad8927-25c8-da0e-e053-3705fe0a2b96
|
9
|
|
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites, file e3ad8927-519f-da0e-e053-3705fe0a2b96
|
9
|
|
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach, file e3ad8927-6cb5-da0e-e053-3705fe0a2b96
|
9
|
|
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices, file 86d1e742-6aec-43f8-b349-32d4e87bfae6
|
8
|
|
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial., file e3ad891e-b6e1-da0e-e053-3705fe0a2b96
|
8
|
|
Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort, file e3ad891e-faad-da0e-e053-3705fe0a2b96
|
8
|
|
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals, file e3ad8923-d6a4-da0e-e053-3705fe0a2b96
|
8
|
|
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study, file e3ad8927-3c73-da0e-e053-3705fe0a2b96
|
8
|
|
Inflammation and autonomic balance in cirrhosis: Association between sympathetic nervous system and osteopontin, interleukin-22, interleukin-6 and interleukin-1Ra concentrations according to portal hypertension and disease severity, file 2f522bb0-202d-4f21-9db4-c3c86ec8c72e
|
7
|
|
Child-Pugh Class and Not Thrombocytopenia Impacts the Risk of Complications of Endoscopic Band Ligation in Patients with Cirrhosis and High Risk Varices, file b70d840b-95e0-49ea-bfa4-a0c7daa8e837
|
7
|
|
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study, file d0376914-02e8-4f1e-a898-cd51f40e8b9f
|
7
|
|
Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model, file e3ad8919-70a4-da0e-e053-3705fe0a2b96
|
7
|
|
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy, file e3ad8927-204f-da0e-e053-3705fe0a2b96
|
7
|
|
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development, file f2680e2e-bfb9-42b4-a4cf-e6b5d695702e
|
7
|
|
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study, file 28bec8b0-2af6-45a0-8ab7-3dbf18829309
|
6
|
|
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients, file e3ad8921-8e4f-da0e-e053-3705fe0a2b96
|
6
|
|
Hepatitis C Virus Eradication by Direct Antiviral Agents Improves Carotid Atherosclerosis in patients with Severe Liver Fibrosis, file e3ad8923-d994-da0e-e053-3705fe0a2b96
|
6
|
|
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP), file e3ad8927-13f3-da0e-e053-3705fe0a2b96
|
5
|
|
Depth effect on point shear wave velocity elastography: Evidence in a chronic hepatitis C patient cohort, file 178f60a9-c985-4d3b-9ada-5e965e42f789
|
4
|
|
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model, file dd42994e-737f-40ae-9c4b-ef8c000976fe
|
4
|
|
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension, file e3ad8919-7e1f-da0e-e053-3705fe0a2b96
|
4
|
|
Real life experiences in HCV management in 2018, file e3ad891e-b1e4-da0e-e053-3705fe0a2b96
|
4
|
|
Hepatic benefits of HCV cure, file e3ad8926-abdb-da0e-e053-3705fe0a2b96
|
4
|
|
Towards personalized screening for hepatocellular carcinoma: Still not there, file e3ad8927-07a9-da0e-e053-3705fe0a2b96
|
4
|
|
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals, file e3ad8927-20b0-da0e-e053-3705fe0a2b96
|
4
|
|
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C, file e3ad8927-35af-da0e-e053-3705fe0a2b96
|
4
|
|
Real-world experience with obeticholic acid in patients with primary biliary cholangitis., file e3ad8927-7e68-da0e-e053-3705fe0a2b96
|
4
|
|
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort, file 493c05b8-bc36-42ad-8d21-7ca537d6f596
|
3
|
|
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis, file 70da8aa5-996a-474e-889f-de7a503d5829
|
3
|
|
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy, file e3ad8916-5aa9-da0e-e053-3705fe0a2b96
|
3
|
|
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents, file e3ad891d-5f52-da0e-e053-3705fe0a2b96
|
3
|
|
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D., file e3ad891e-b6dd-da0e-e053-3705fe0a2b96
|
3
|
|
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study), file e3ad8920-83a7-da0e-e053-3705fe0a2b96
|
3
|
|
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? the REAL Experience, file e3ad8920-a956-da0e-e053-3705fe0a2b96
|
3
|
|
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis, file e3ad8925-2cc5-da0e-e053-3705fe0a2b96
|
3
|
|
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data, file e3ad8926-83e0-da0e-e053-3705fe0a2b96
|
3
|
|
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study, file e3ad8926-c2e0-da0e-e053-3705fe0a2b96
|
3
|
|
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b., file e3ad8927-2dc4-da0e-e053-3705fe0a2b96
|
3
|
| Totale |
14.737 |